Cargando…
Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
Minimally invasive surgery may not be an appropriate surgical approach in intermediate- and high-risk endometrial carcinoma, even though adjuvant therapy is given. The objective of this study was to evaluate the results of open surgery including lymphadenectomy without adjuvant therapy in patients w...
Autores principales: | Otsuka, Isao, Matsuura, Takuto, Mitani, Takahiro, Otsuka, Koji, Kanamoto, Yoshihisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139559/ https://www.ncbi.nlm.nih.gov/pubmed/35621688 http://dx.doi.org/10.3390/curroncol29050298 |
Ejemplares similares
-
Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy
por: Otsuka, Isao
Publicado: (2022) -
Long-term survival of a patient with stage IIIC2 grade 3 endometrioid endometrial carcinoma treated with surgery alone
por: Otsuka, Isao, et al.
Publicado: (2021) -
Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002) -
Does tumor size have prognostic value in patients undergoing lymphadenectomy in endometrioid-type endometrial cancer confined to the uterine corpus?
por: ÇAKIR, Caner, et al.
Publicado: (2019) -
High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: does adjuvant therapy improve survival?
por: Kılıç, Çiğdem, et al.
Publicado: (2019)